HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jason D Warren Selected Research

Primary Progressive Nonfluent Aphasia (Progressive Nonfluent Aphasia)

3/2023Symptom-led staging for primary progressive aphasia.
3/2012Receptive prosody in nonfluent primary progressive aphasias.
7/2011Auditory object cognition in dementia.
6/2010Phenomenology and anatomy of abnormal behaviours in primary progressive aphasia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jason D Warren Research Topics

Disease

20Frontotemporal Dementia (Semantic Dementia)
01/2023 - 06/2010
18Alzheimer Disease (Alzheimer's Disease)
01/2020 - 08/2010
16Primary Progressive Aphasia
05/2024 - 01/2010
12Dementia (Dementias)
01/2023 - 07/2011
12Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar)
01/2020 - 01/2004
8Neurodegenerative Diseases (Neurodegenerative Disease)
12/2023 - 07/2012
7Atrophy
04/2024 - 04/2010
5Aphasia (Dysphasia)
12/2022 - 06/2010
5Pick Disease of the Brain (Pick's Disease)
01/2021 - 09/2005
4Primary Progressive Nonfluent Aphasia (Progressive Nonfluent Aphasia)
03/2023 - 06/2010
4Tauopathies
12/2019 - 09/2012
3Cognitive Dysfunction
04/2024 - 12/2015
2Hearing Loss (Hearing Impairment)
04/2024 - 06/2017
2Proteostasis Deficiencies
10/2023 - 06/2015
2Neuroinflammatory Diseases
10/2021 - 01/2018
2Stroke (Strokes)
08/2017 - 06/2017
2Disease Progression
03/2015 - 04/2012
2Paralysis (Palsy)
04/2010 - 05/2002
1Death (Near-Death Experience)
01/2020
1Parkinsonian Disorders (Parkinsonism)
01/2020
1Leukoencephalopathies
08/2017
1Sensorineural Hearing Loss
06/2017
1Language Development Disorders (Semantic-Pragmatic Disorder)
06/2017
1Parkinson Disease (Parkinson's Disease)
11/2016
1Asymptomatic Diseases
03/2015
1Amnesia (Dissociative Amnesia)
01/2015
1Amyloid Plaque
11/2013
1Prion Diseases (Transmissible Spongiform Encephalopathies)
11/2013
1Diarrhea
11/2013
1Cerebral Amyloid Angiopathy (Congophilic Angiopathy)
11/2013
1Agnosia (Visual Agnosia)
08/2013
1Prosopagnosia
08/2013
1Huntington Disease (Huntington's Disease)
04/2012
1Rare Diseases (Rare Disease)
09/2011
1Corticobasal Degeneration
09/2011
1Sarcoma (Soft Tissue Sarcoma)
09/2011
1Cytomegalovirus Infections (Inclusion Disease)
09/2011
1Dysarthria (Spastic Dysarthria)
08/2011
1Osteitis Deformans (Paget's Disease of Bone)
08/2011
1Inclusion Body Myositis
08/2011
1Broca Aphasia (Expressive Aphasia)
08/2010
1Respiratory Insufficiency (Respiratory Failure)
04/2010
1Dyskinesias (Dyskinesia)
04/2010
1Brain Diseases (Brain Disorder)
04/2007
1Partial Epilepsies (Epilepsy, Partial)
05/2006
1Waldenstrom Macroglobulinemia (Macroglobulinemia)
06/2003
1Mononeuropathies (Mononeuritis Multiplex)
06/2003
1Encephalomyelitis (Myeloencephalitis)
05/2002

Drug/Important Bio-Agent (IBA)

21Biomarkers (Surrogate Marker)IBA
12/2022 - 01/2015
13ProgranulinsIBA
12/2022 - 03/2008
11Proteins (Proteins, Gene)FDA Link
10/2020 - 01/2004
10Amyloid (Amyloid Fibrils)IBA
04/2024 - 01/2013
3DNA-Binding Proteins (DNA Binding Protein)IBA
12/2019 - 03/2012
3Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
06/2015 - 09/2011
3UbiquitinIBA
09/2011 - 09/2005
2Levodopa (L Dopa)FDA LinkGeneric
01/2021 - 04/2010
2PrionsIBA
01/2020 - 11/2014
2LipidsIBA
09/2019 - 01/2019
2Biological FactorsIBA
01/2019 - 04/2013
2Donepezil (Aricept)FDA LinkGeneric
01/2018 - 11/2017
2Prion ProteinsIBA
11/2013 - 11/2006
2Sodium Glutamate (Accent)IBA
08/2013 - 07/2012
2DNA (Deoxyribonucleic Acid)IBA
03/2012 - 09/2011
2AntibodiesIBA
04/2007 - 05/2002
1Complement System Proteins (Complement)IBA
12/2023
1Temazepam (Nocturne)FDA LinkGeneric
10/2023
1MicroRNAs (MicroRNA)IBA
01/2023
1ChemokinesIBA
10/2021
1Glial Fibrillary Acidic ProteinIBA
11/2020
17- (6- fluoropyridin- 3- yl)- 5H- pyrido(4,3- b)indoleIBA
01/2020
1chitotriosidaseIBA
01/2020
1ApolipoproteinsIBA
12/2019
1Apolipoprotein E4IBA
12/2019
1Apolipoproteins E (ApoE)IBA
12/2019
1Carrier Proteins (Binding Protein)IBA
01/2019
1Amyloid beta-PeptidesIBA
01/2018
1AcetylcholinesteraseIBA
11/2017
1Cathepsin AIBA
08/2017
1Phosphotransferases (Kinase)IBA
01/2017
1HLA-DR alpha-ChainsIBA
02/2016
1Lamotrigine (Lamictal)FDA LinkGeneric
01/2015
1Presenilin-1IBA
01/2013
1Genetic Markers (Genetic Marker)IBA
04/2012
1Alkaline PhosphataseIBA
08/2011
1Valosin Containing ProteinIBA
08/2011
1SteroidsIBA
04/2007
1alpha-SynucleinIBA
09/2005
1tau Proteins (tau Protein)IBA
01/2004
1Immunoglobulin M (IgM)IBA
06/2003
1ParaproteinsIBA
06/2003

Therapy/Procedure

6Language Therapy (Language Training)
10/2023 - 01/2018
2Therapeutics
10/2023 - 04/2010
2Aftercare (After-Treatment)
01/2015 - 05/2006
1PPA protocol
05/2024
1Activities of Daily Living (ADL)
03/2023
1Patient Care
01/2020
1Palliative Care (Palliative Therapy)
01/2020
1Patient Transfer (Patient Dumping)
01/2020
1Transcranial Magnetic Stimulation
01/2018
1Continuous Ambulatory Peritoneal Dialysis (CAPD)
06/2017